(Q38960225)

8 September 2017

1 reference

title

Beyond the hype and hope: Critical considerations for intranasal oxytocin research in autism spectrum disorder (English)

1 reference

8 September 2017

main subject

autism spectrum disorder

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Daniel S. Quintana

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

Andrew Whitehouse

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

3

Andrew J O Whitehouse

1 reference

8 September 2017

publication date

21 September 2016

1 reference

8 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

page(s)

25-41

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

Intravenous oxytocin alone for cervical ripening and induction of labour

1 June 2020

cites work

1 reference

Oxytocin enhances orienting to social information in a selective group of high-functioning male adults with autism spectrum disorder

21 January 2018

1 reference

Clearance studies of oxytocin in humans using radioimmunoassay measurements of the hormone in plasma and urine.

21 January 2018

1 reference

Intranasal oxytocin in the treatment of autism spectrum disorders: a review of literature and early safety and efficacy data in youth

21 January 2018

1 reference

Intranasal oxytocin versus placebo in the treatment of adults with autism spectrum disorders: a randomized controlled trial

21 January 2018

1 reference

Promoting social behavior with oxytocin in high-functioning autism spectrum disorders

21 January 2018

1 reference

Oxytocin's neurochemical effects in the medial prefrontal cortex underlie recovery of task-specific brain activity in autism: a randomized controlled trial.

21 January 2018

1 reference

Oxytocin improves behavioural and neural deficits in inferring others' social emotions in autism.

21 January 2018

1 reference

Oxytocin increases eye contact during a real-time, naturalistic social interaction in males with and without autism

21 January 2018

1 reference

A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans

21 January 2018

1 reference

The "Reading the Mind in the Eyes" Test Revised Version: A Study with Normal Adults, and Adults with Asperger Syndrome or High-functioning Autism

21 January 2018

1 reference

Oxytocin shapes the neural circuitry of trust and trust adaptation in humans

21 January 2018

1 reference

An exploratory study of neurohormonal responses of healthy men to massage

21 January 2018

1 reference

Oxytocin, brain physiology, and functional connectivity: a review of intranasal oxytocin fMRI studies

21 January 2018

1 reference

Synthesis, Transport, and Release of Posterior Pituitary Hormones

21 January 2018

1 reference

A double-blind randomized controlled trial of oxytocin nasal spray and social cognition training for young people with early psychosis

21 January 2018

1 reference

Association of oxytocin receptor (OXTR) gene variants with multiple phenotype domains of autism spectrum disorder

21 January 2018

1 reference

Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children

21 January 2018

1 reference

Placebo Responses in Genetically Determined Intellectual Disability: A Meta-Analysis

21 January 2018

1 reference

Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial

21 January 2018

1 reference

CSF and blood oxytocin concentration changes following intranasal delivery in macaque

21 January 2018

1 reference

Oxytocin-augmented social cognitive skills training in schizophrenia

21 January 2018

1 reference

The nasal approach to delivering treatment for brain diseases: an anatomic, physiologic, and delivery technology overview

21 January 2018

1 reference

Breath actuated device improves delivery to target sites beyond the nasal valve

21 January 2018

1 reference

Oxytocin improves "mind-reading" in humans

21 January 2018

1 reference

Effects of intranasal oxytocin on the neural basis of face processing in autism spectrum disorder

21 January 2018

1 reference

Oxytocin differentially modulates eye gaze to naturalistic social signals of happiness and anger

21 January 2018

1 reference

Oxytocin promotes facial emotion recognition and amygdala reactivity in adults with asperger syndrome

21 January 2018

1 reference

Adjunctive intranasal oxytocin reduces symptoms in schizophrenia patients

21 January 2018

1 reference

Social amnesia in mice lacking the oxytocin gene.

21 January 2018

1 reference

Randomised, double blind trial of oxytocin nasal spray in mothers expressing breast milk for preterm infants

21 January 2018

1 reference

Interplay of oxytocin, vasopressin, and sex hormones in the regulation of social recognition.

21 January 2018

1 reference

Different amygdala subregions mediate valence-related and attentional effects of oxytocin in humans

21 January 2018

1 reference

Oxytocin enhances brain function in children with autism

21 January 2018

1 reference

Parent-mediated communication-focused treatment in children with autism (PACT): a randomised controlled trial

21 January 2018

1 reference

Genomic and epigenetic evidence for oxytocin receptor deficiency in autism

21 January 2018

1 reference

Effects of partner support on resting oxytocin, cortisol, norepinephrine, and blood pressure before and after warm partner contact

21 January 2018

1 reference

Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers

21 January 2018

1 reference

Intranasal oxytocin improves emotion recognition for youth with autism spectrum disorders

21 January 2018

1 reference

The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial

21 January 2018

1 reference

Recommendations for the standardisation of oxytocin nasal administration and guidelines for its reporting in human research

21 January 2018

1 reference

Oxytocin increases gaze to the eye region of human faces

21 January 2018

1 reference

Effects of intranasal oxytocin on social anxiety in males with fragile X syndrome

21 January 2018

1 reference

Effects of suckling on hypothalamic-pituitary-adrenal axis responses to psychosocial stress in postpartum lactating women

21 January 2018

1 reference

CD38 and its role in oxytocin secretion and social behavior.

21 January 2018

1 reference

Oxytocin increases retention of social cognition in autism

21 January 2018

1 reference

Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders

21 January 2018

1 reference

Oxytocin receptor distribution reflects social organization in monogamous and polygamous voles

21 January 2018

1 reference

DNA methylation of the oxytocin receptor gene predicts neural response to ambiguous social stimuli

21 January 2018

1 reference

Autonomic and neuroendocrine responses to a psychosocial stressor in adults with autistic spectrum disorder

21 January 2018

1 reference

CD38 is critical for social behaviour by regulating oxytocin secretion

21 January 2018

1 reference

Liquid chromatography-mass spectrometry platform for both small neurotransmitters and neuropeptides in blood, with automatic and robust solid phase extraction

21 January 2018

1 reference

Plasma oxytocin and vasopressin do not predict neuropeptide concentrations in human cerebrospinal fluid.

21 January 2018

1 reference

Effect of oxytocin on placebo analgesia: a randomized study

21 January 2018

1 reference

Baseline factors predicting placebo response to treatment in children and adolescents with autism spectrum disorders: a multisite randomized clinical trial

21 January 2018

1 reference

Oxytocin Modulates Neural Circuitry for Social Cognition and Fear in Humans

21 January 2018

1 reference

Long-term oxytocin administration improves social behaviors in a girl with autistic disorder

21 January 2018

1 reference

Oxytocin increases trust in humans

21 January 2018

1 reference

Epigenetic regulation of the oxytocin receptor gene: implications for behavioral neuroscience

21 January 2018

1 reference

Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication

21 January 2018

1 reference

Intranasal Oxytocin: Myths and Delusions

21 January 2018

1 reference

Neuropeptidergic regulation of affiliative behavior and social bonding in animals

21 January 2018

1 reference

The effect of intranasal oxytocin versus placebo treatment on the autonomic responses to human sounds in autism: a single-blind, randomized, placebo-controlled, crossover design study

21 January 2018

1 reference

The oxytocin receptor gene (OXTR) is associated with autism spectrum disorder: a meta-analysis

21 January 2018

1 reference

Dendritic peptide release and peptide-dependent behaviours

21 January 2018

1 reference

The neuropeptide oxytocin facilitates pro-social behavior and prevents social avoidance in rats and mice

21 January 2018

1 reference

A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research.

21 January 2018

1 reference

Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents

21 January 2018

1 reference

Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis

21 January 2018

1 reference

Problems with measuring peripheral oxytocin: can the data on oxytocin and human behavior be trusted?

21 January 2018

1 reference

Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine

21 January 2018

1 reference

Neuroscience. The promise and perils of oxytocin

21 January 2018

1 reference

Oxytocin and vasopressin in children and adolescents with autism spectrum disorders: sex differences and associations with symptoms

21 January 2018

1 reference

Plasma oxytocin levels in autistic children.

21 January 2018

1 reference

The oxytocin system in drug discovery for autism: animal models and novel therapeutic strategies

21 January 2018

1 reference

Aerosolized oxytocin increases cerebrospinal fluid oxytocin in rhesus macaques

21 January 2018

1 reference

Two genetic variants of CD38 in subjects with autism spectrum disorder and controls.

21 January 2018

1 reference

Does Oxytocin Increase Trust in Humans? A Critical Review of Research

21 January 2018

1 reference

Involvement of the brain oxytocin system in stress coping: interactions with the hypothalamo-pituitary-adrenal axis

21 January 2018

1 reference

Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder.

21 January 2018

1 reference

Induction of maternal behavior in virgin rats after intracerebroventricular administration of oxytocin

21 January 2018

1 reference

Do delivery routes of intranasally administered oxytocin account for observed effects on social cognition and behavior? A two-level model.

21 January 2018

1 reference

Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.

21 January 2018

1 reference

The promise and pitfalls of intranasally administering psychopharmacological agents for the treatment of psychiatric disorders

21 January 2018

1 reference

Fragile X syndrome: assessment and treatment implications

21 January 2018

1 reference

Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism

21 January 2018

1 reference

The impact of a single administration of intranasal oxytocin on the recognition of basic emotions in humans: a meta-analysis

21 January 2018

1 reference

Intranasal administration of oxytocin increases envy and schadenfreude (gloating).

21 January 2018

1 reference

Elevated cerebrospinal fluid and blood concentrations of oxytocin following its intranasal administration in humans

21 January 2018

1 reference

Adolescent exposure to oxytocin, but not the selective oxytocin receptor agonist TGOT, increases social behavior and plasma oxytocin in adulthood.

21 January 2018

1 reference

Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders

21 January 2018

1 reference

Oxytocin may be useful to increase trust in others and decrease disruptive behaviours in patients with Prader-Willi syndrome: a randomised placebo-controlled trial in 24 patients

21 January 2018

1 reference

Oxytocin treatment in pediatric populations

21 January 2018

1 reference

Are plasma oxytocin in women and plasma vasopressin in men biomarkers of distressed pair-bond relationships?

21 January 2018

1 reference

THE SYNTHESIS OF AN OCTAPEPTIDE AMIDE WITH THE HORMONAL ACTIVITY OF OXYTOCIN

21 January 2018

1 reference

Opposite effects of oxytocin and vasopressin on the emotional expression of the fear response

21 January 2018

1 reference

Statistical and Methodological Considerations for the Interpretation of Intranasal Oxytocin Studies

21 January 2018

1 reference

A comprehensive meta-analysis of common genetic variants in autism spectrum conditions

21 January 2018

1 reference

Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial

21 January 2018

1 reference

Clinical and neural effects of six-week administration of oxytocin on core symptoms of autism.

21 January 2018

1 reference

Neurophysiological effects of acute oxytocin administration: systematic review and meta-analysis of placebo-controlled imaging studies.

21 January 2018

1 reference

The effect of oxytocin nasal spray on social interaction deficits observed in young children with autism: a randomized clinical crossover trial

21 January 2018

1 reference

The neurobiology of pair bonding

21 January 2018

1 reference

Genes controlling affiliative behavior as candidate genes for autism

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AUR.1692

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27651096%20AND%20SRC:MED&resulttype=core&format=json

1 June 2020

1 reference